Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.
暂无分享,去创建一个
J. Crook | K. Gulenchyn | A. McEwan | A. Porter | G. Thomas | A J McEwan | A T Porter | H Lukka | A. Mcewan | R. Reid | D G McGowan | J E Powe | R Reid | J R Sathyanarayana | V N Yakemchuk | G M Thomas | L E Erlich | H. Lukka | J. Powe | V. Yakemchuk | D. McGowan | J. Yardley | Gillian Thomas | J. R. Sathyanarayana | L. Erlich | C. Wesolowski | K. Hong
[1] A. McEwan,et al. Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate , 1986, European Journal of Nuclear Medicine.
[2] M. Rotman,et al. Comparison of 32P Therapy and Sequential Hemibody Irradiation (HBI) for Bony Metastases as Methods of Whole Body Irradiation , 1986, American journal of clinical oncology.
[3] J. A. Spicer,et al. Treatment of metastatic bone pain with strontium-89. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[4] P. Rubin,et al. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. , 1992, International journal of radiation oncology, biology, physics.
[5] A. McEwan,et al. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. , 1991, The British journal of radiology.
[6] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[7] A. Porter,et al. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] R. Dhaliwal,et al. Half and total body radiation for carcinoma of the prostate. , 1979, The Journal of urology.
[9] J. Montebello,et al. The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective. , 1989, Cancer investigation.
[10] E. Silberstein,et al. Strontium-89 therapy for the pain of osseous metastases. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] G. Wetherill,et al. Elementary Statistical Methods. , 1969 .
[12] R. Kloiber,et al. Sr-89 therapy for metastatic bone disease: scintigraphic and radiographic follow-up. , 1987, Radiology.
[13] A. E. El Hassan,et al. Palliation of multiple bone metastases from prostatic carcinoma with strontium-89. , 1988, Acta oncologica.
[14] P. Fitzpatrick,et al. Half body radiotherapy , 1976 .
[15] R. Twycross,et al. Symptom Control in Far Advanced Cancer: Pain Relief , 1983 .
[16] G. Hibbs,et al. Effective bone palliation as related to various treatment regimens , 1976, Cancer.
[17] F. Freiha,et al. Carcinoma of the prostate: pathology, staging, and treatment. , 1988, Current problems in cancer.
[18] D. Tong,et al. The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group , 1982, Cancer.
[19] A. McEwan,et al. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. , 1991, European journal of cancer.